Fig. 00 · A field guide to peptide science
Short chains of amino acids carry your body's signals — healing, growth, metabolism, mood. This guide explains what they are, how they work, what the research actually shows, and where the science stops.
New: the Plain-English Edition → — same guide, zero lab talk.
Fig. 01 · The primer
Strip biology down to its working parts and you find strings of amino acids. String a few together — two to fifty of them — and you have a peptide. Keep the chain growing past roughly fifty and it folds into something bigger: a protein. Same chemistry, different scale.
Your body runs on these short strings. Oxytocin — the bonding hormone — is nine residues. Glucagon — blood sugar's failsafe — is twenty-nine. GHK, the copper-binding tripeptide drawn above, is three, and its blood levels fall as you age. The twenty standard amino acids are the alphabet; the sequence is the word; and the word is the message your cells read.
Most peptides discussed in research circles are synthetic copies of these endogenous signals — or engineered tweaks of them, built one amino acid at a time to last longer, hit harder, or aim cleaner than nature's original.
Fig. 02 · The mechanism
Four moves, repeated everywhere in your biology. Learn them once and every peptide article you read afterward starts making sense.
The order of amino acids decides how the short chain folds — a helix, a turn, a stiff little rod. Shape is the payload; the sequence only exists to produce it.
Cell surfaces are covered in receptors — proteins that change behavior when something docks into them. A peptide with the right shape binds like a key into a lock, as an agonist (turning the receptor on) or an antagonist (blocking it).
A single bound receptor flips intracellular switches — second messengers, gene transcription, enzyme release. Small cause, loud effect: that's why microgram doses are the whole conversation.
Natural peptides are fragile — enzymes shred them in minutes. Swap a residue for an unnatural one, cap an end, or glue on a fatty side-chain, and half-life stretches from minutes to a week.
Fig. 03 · The spectrum
The same peptide can be a lab reagent, a compounded medicine, or an approved blockbuster drug. The difference is not chemistry — it's manufacturing, evidence, and the claims a seller is allowed to make. This is the single most useful thing to understand in this entire market.
Manufactured for in-vitro, cell and animal studies. No GMP sterility or purity guarantees. Sold legally only when labeled "for research use only — not for human consumption" and marketed without human-use claims.
Prepared by licensed compounding pharmacies under FDA rules for individual prescriptions — a legal lane distinct from both RUO reagents and finished drugs, with real oversight but no clinical-trial requirement.
Clinical trials completed. Controlled dosing, pharmacovigilance, a real label with real risks on it. Semaglutide (2017) and tirzepatide (2022/23) prove peptides can finish the entire journey — and become blockbusters doing it.
The molecule doesn't change. The manufacturing, the evidence, and the claims do. Judge every seller — and every headline — by which tier they're standing in.
Fig. 04 · The index
The compounds people actually talk about, each with its mechanism, what the research genuinely shows — and the catch. No dosing advice, no hype. Search it, filter it, open each row.
Fig. 05 · The standards
In a market where the same molecule can ship from a GMP suite or from a bathtub, quality is the entire product. This is how labs — and honest buyers — check.
HPLC ≥99% is table stakes. What separates vendors is whether they show you the chromatogram — the actual trace — or just type the number. Ask for the trace.
Mass spectrometry (LC-MS) verifies the molecule is what the label claims. A purity number without an identity method is a rumor.
Certificate of Analysis, tied to a batch number you can match to the vial in hand — visible before you commit. If the batch number isn't published, the paper is decoration.
Research peptides ship lyophilized (freeze-dried), stored cold and dark, reconstituted in the lab with bacteriostatic water, and used promptly. Lab practice, not lifestyle advice.
| PRODUCT | BPC-157 (acetate) |
| BATCH | PF-2610-A |
| METHOD — PURITY | HPLC, UV 214 nm |
| PURITY | ≥ 99.2% |
| METHOD — IDENTITY | LC-MS, m/z confirmed |
| NET CONTENT | 10 mg lyophilized |
| INTENDED USE | Laboratory research only |
| RESULT | PASS |
Three checks, in order. One: the batch number on the certificate matches the lot on the vial being sold today — not a template from a different batch. Two: there are two methods, not one — HPLC for purity, LC-MS for identity. Three: a real lab name you can independently verify. If all three hold, you're looking at a vendor that respects the science. If any is missing, close the tab.
Fig. 06 · Questions, answered plainly
Usually the molecule isn't the issue — the claims are. Research peptides are sold legally in the US when clearly labeled for laboratory research and marketed without human-use promises. The moment a site adds dosage guidance or benefit claims, it drifts into drug-marketing territory: FDA warning letters follow, and payment processors terminate. This is not legal advice.
RUO is the regulatory lane that lets compounds be sold for laboratory study without being approved drugs. It comes with obligations: explicit labeling, no human-use claims, honest disclaimers. A vendor that respects the lane stays in business; one that blurs it gets everyone — itself, its processor, its customers — into trouble.
Depends entirely which one. Semaglutide and tirzepatide are approved drugs with large cardiovascular and metabolic outcome trials — proven, by the highest standard medicine has. BPC-157 has decades of compelling rodent data and zero registered human trials — promising, unproven in people. Everything else in this market falls somewhere on that line; check the tier badge on each index entry before believing a headline.
Approved peptide drugs carry controlled dosing, trial data and pharmacovigilance. Research-grade compounds carry none of that: they are not manufactured to drug-grade sterility or purity standards. In 2026 several state medical boards formally warned clinicians against administering RUO compounds to patients for exactly this reason. "Cutting-edge" is not a regulatory category.
Match the batch number to the vial, demand two methods (HPLC purity + LC-MS identity), and verify the lab's name independently. Fifteen seconds, three checks — the Standards section above walks through each.
BPC-157 and TB-500 are prohibited at all times under the WADA Prohibited List, and tests exist for them. It doesn't matter whether the athlete believed the "research" label — adverse findings have ended careers and stripped medals.
Fig. 07 · Keep following the chain
One compound, one mechanism, one honest label at a time. This guide grows as the science does — new entries, new evidence tiers, new notes from the literature as they land.
Educational demo — the form stores nothing and sends nothing.